Akebia Therapeutics (AKBA) Other Accumulated Expenses (2013 - 2020)
Akebia Therapeutics' Other Accumulated Expenses was $54.58 million in Q1 2020, down 28.6% from $76.44 million a year earlier and down 11.7% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Other Accumulated Expenses (2013 - 2020) Analysis & Trends
At the end of FY2019, Other Accumulated Expenses at Akebia Therapeutics came in at $61.82 million, down 14.0% from FY2018.
- Other Accumulated Expenses shows a five-year compound annual growth rate of 157.2% (FY2014 to FY2019).
- In earlier years, Other Accumulated Expenses was $71.88 million in FY2018 (+66.0%), $43.3 million in FY2017, $1.95 million in FY2016 (+42.5%) and $1.37 million in FY2015 (+148.8%).
- The Q1 2020 figure marks the lowest quarterly Other Accumulated Expenses since Q1 2018.
- Compared with a year earlier, Other Accumulated Expenses has declined for three straight quarters, with growth averaging 92.8% over the last eight quarters.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q3 2017 (growth of 617.1%); the worst was Q1 2020 (a decline of 28.6%).
- Per Business Quant data, AKBA's Other Accumulated Expenses in the three quarters before Q1 2020 was $61.82 million (Q4 2019), $66.19 million (Q3 2019) and $68.82 million (Q2 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Akebia Therapeutics | 236.42 Mn | -433.06 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 54.58 Mn |
| Dec 31, 2019 | 61.82 Mn |
| Sep 30, 2019 | 66.19 Mn |
| Jun 30, 2019 | 68.82 Mn |
| Mar 31, 2019 | 76.44 Mn |
| Dec 31, 2018 | 71.88 Mn |
| Sep 30, 2018 | 80.32 Mn |
| Jun 30, 2018 | 65.97 Mn |
| Mar 31, 2018 | 46.27 Mn |
| Dec 31, 2017 | 43.30 Mn |
| Sep 30, 2017 | 13.98 Mn |
| Jun 30, 2017 | 22.58 Mn |
| Mar 31, 2017 | 2.32 Mn |
| Dec 31, 2016 | 1.95 Mn |
| Sep 30, 2016 | 1.95 Mn |
| Jun 30, 2016 | 2.05 Mn |
| Mar 31, 2016 | 1.31 Mn |
| Dec 31, 2015 | 1.37 Mn |
| Sep 30, 2015 | 999,000.00 |
| Jun 30, 2015 | 596,000.00 |
API Access
Akebia Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();